NBIX
Neurocrine Biosciences Inc
143.20$
+1.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.63 | -0.45 | -1.22 | -1.07 | 1.06 | 1.54 | 2.34 | 2.62 | 3.43 | 3.86 | 5.74 | 7.64 | |
| 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | 0.08 | 0.09 | 0.11 | 0.16 | 0.21 | 0.26 | 0.29 | |
| 0.14 | 0.34 | 0.33 | 0.48 | 0.61 | 0.79 | 1.02 | 1.37 | 1.75 | 1.92 | 1.89 | 2.13 | |
| 0.10 | 0.30 | 0.29 | 0.46 | 0.60 | 0.79 | -1.93 | 1.46 | 2.69 | – | – | – | |
| 0.02 | 0.10 | 0.07 | -0.10 | -0.02 | -0.05 | -0.39 | 0.17 | -0.68 | 0.28 | -0.19 | -1.26 | |
| 0.02 | 0.02 | 0.05 | 0.08 | 0.26 | 0.15 | 0.11 | 0.24 | 0.17 | 0.28 | 0.37 | 0.33 | |
| -1.41 | -2.32 | 1.30 | -2.85 | -2.55 | -2.21 | 0.04 | -1.33 | -1.79 | -4.62 | -1.22 | -2.58 | |
| 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | |
| 1.86 | 3.28 | 0.03 | 0.16 | 0.31 | 0.29 | 0.30 | 0.28 | 0.45 | 0.00 | -2.89 | -1.64 | |
| 6.74 | 5.95 | 5.80 | 5.71 | -1.96 | -1.95 | -1.91 | 0.00 | -2.82 | 0.00 | -2.98 | 0.00 | |
| 1.86 | 3.28 | 0.03 | 5.87 | 0.31 | 0.34 | -1.61 | 0.28 | -2.37 | 0.65 | -4.69 | -0.37 | |
| -0.18 | 0.51 | 0.11 | 1.94 | -1.17 | -0.33 | 0.76 | 1.57 | -0.74 | -0.11 | -0.17 | 4.68 | |
| -0.65 | -0.47 | -1.27 | -1.15 | 0.80 | 1.38 | 2.22 | 2.38 | 3.26 | 3.58 | 5.37 | 7.30 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.